Metabolomic Diagnostics
Improving Pregnancy Outcomes Globally
- Headquarters
- Little Island
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- metabolomicdiagnostics.com
- Total Funding
- $4.3M
- Last Round
- $2.2M GrantMay 2018
About
Metabolomic Diagnostics is a deep-tech company developing novel biomarker-based diagnostic solutions for complex diseases in pregnancy. The company's primary focus is an early-pregnancy screening test to identify women at risk of preeclampsia, gestational diabetes, and preterm birth, enabling personalized prenatal care. Its pipeline translates metabolomics biomarker panels into clinical laboratory assays.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account